IL-33/ST2 SIGNALING PROMOTES THE PROLIFERATION OF AML1/ETO LEUKEMIC STEM CELLS

EHA Library, Pascal Näf, 294367

CD44-INDUCED VLA-4 CLUSTERS AS COMMUNICATION HUBS OF LEUKEMIA CELLS WITH THE BONE MARROW ENVIRONMENT

EHA Library, Tanja Nicole Hartmann, 294368

DIFFERENTIATION THERAPY WITH NOVEL EPIGENETIC INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Edurne San Jose-Eneriz, 294369

ACUTE MYELOID LEUKEMIA SHAPES THE BONE MARROW STROMAL NICHE IN VIVO

EHA Library, Marta Biondi, 294370

EPIGENETIC AND IMMUNOMODULATORY EFFECTS OF AZACITIDINE (AZA) IN COMBINATION WITH THE ANTI-PD-L1 DURVALUMAB (DURVA) IN AML AND MDS: RESULTS FROM A LARGE, INTERNATIONAL, RANDOMIZED PHASE 2 STUDY

EHA Library, Isaac Boss, 294371

SELECTIVE DELIVERY OF ARA-C TO CXCR4+ CELLS, USING THE NANOCONJUGATE T22-GFP-H6-ARA-C, BLOCKS LEUKEMIA DISSEMINATION

EHA Library, Yáiza Núñez Amela, 294372

ACUTE MYELOID LEUKEMIA CELLS RESIST CHEMOTHERAPY THROUGH A TRANSIENT SENESCENCE-LIKE STATE

EHA Library, Cihangir Duy, 294373

PHARMACODYNAMIC (PD) RESPONSES TO CC-90009, A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD), IN A PHASE 1 DOSE-ESCALATION STUDY IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (RR AML)

EHA Library, Daniel Pierce, 294374

NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE (MRD) MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION (FLT3-ITD+ AML) TREATED WITH ADDITIONAL MIDOSTAURIN

EHA Library, Julia K. Herzig, 294375

INTER-LABORATORY COMPARABILITY OF QUANTITATIVE ASSESSMENT OF MUTANT NPM1: RESULTS OF THE FIRST INTERNATIONAL ROUND-ROBIN TEST PERFORMED BY THE EUROPEAN LEUKEMIA NET (ELN) MRD WORKING PARTY (WP)

EHA Library, Christian Thiede, 294376

INDUCIBLE KNOCKDOWN IN PATIENT'S LEUKEMIA CELLS IN VIVO ALLOWS IDENTIFYING POTENT DRUG TARGETS IN INDIVIDUAL TUMORS IN A HIGHLY CLINIC-RELATED SETTING

EHA Library, Irmela Jeremias, 294377

PRL-PRLR AXIS AS A NEW POTENTIAL THERAPEUTIC TARGET AGAINST ACUTE MYELOID LEUKEMIA

EHA Library, Laia Cuesta-Casanovas, 294378

PHOSPHOPROTEOMIC PROFILING OF PRIMARY AML SAMPLES TO PREDICT EX VIVO RESPONSE TO FLT3-INHIBITORS.

EHA Library, David GJ Cucchi, 294379

ACTIVATED PENTOSE PHOSPHATE PATHWAY MEDIATED BY FBP1 UPREGULATION SUPPORTS PROGRESSION OF ACUTE MYELOID LEUKEMIA WITH HIGH EVI1 EXPRESSION

EHA Library, Hideaki Mizuno, 294380

SLIT2-KNOCKDOWN IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL AND ARSENIC TRIOXIDE RESISTANCE IN APL CELLS.

EHA Library, Isabel Weinhäuser, 294382

VALIDATION THE OF PROGNOSTIC SIGNIFICANCE OF THE KNOWLEDGE BANK (KB) ALGORITHM IN ADULT ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS) TREATED ON CALGB/ALLIANCE TRIALS AND SUGGESTIONS FOR IMPROVEMENTS

EHA Library, Marius Bill, 294383

AB8939, A NOVEL MICROTUBULE-DESTABILIZING AGENT FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

EHA Library, Olivier Hermine, 294384

SCREENING OF NOVEL HYPOMETHYLATING COMPOUNDS FOR TREATMENT OF MDS/AML USING A SFRP1-DERIVED RECOMBINANT REPORTER SYSTEM

EHA Library, Angelique Ziegfeld, 294385

THE MODE OF ACTION (MOA) OF THE ANTI-CD38 MONOCLONAL ANTIBODY (MAB) ISATUXIMAB IN ELDERLY ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Aintzane Zabaleta, 294386

CLONAL EVOLUTION IN MURINE LEUKEMIA MODELS

EHA Library, Rhea Desai, 294387

MOLECULAR LANDSCAPE OF ACUTE MYELOID LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS

EHA Library, Laurène Fenwarth, 294388

DASATINIB RESPONSE IN AML IS CORRELATED WITH FLT3/ITD, PTPN11 MUTATIONS AND A UNIQUE GENE EXPRESSION SIGNATURE.

EHA Library, Nathali Kaushanski, 294389

VALPROIC ACID DISABLES THE NRF2 ANTI-OXIDANT RESPONSE AND ENHANCES REACTIVE OXYGEN SPECIES-MEDIATED KILLING OF ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Yao Jiang, 294390

SIGNALING PATHWAY ACTIVITY ANALYSIS FOR PREDICTION OF DRUG RESISTANCE AND SENSITIVITY IN PEDIATRIC LEUKEMIAS.

EHA Library, Timofey Lebedev, 294391

THERAPEUTIC TARGETING OF DNA-PKCS WITH M3814 IN COMBINATION WITH CPX-351 (VYXEOS) ACHIEVES PROFOUND LEUKEMIA REDUCTION IN TP53WT AND TP53MUT ACUTE MYELOID LEUKEMIA

EHA Library, Yuki Nishida, 294392

OPTIMIZED CART CELLS TARGETING CD33 FOR TREATMENT OF R/R AML.

EHA Library, Cristina Calvino, 294394

CLINICAL RELEVANCE OF HOST IMMUNE GENETIC VARIATIONS ON THE RISK OF DEVELOPING ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE NUCLEAR CONSORTIUM

EHA Library, Juan Sainz, 294395

HIGHLY SENSITIVE MULTIDIMENSIONAL FLOW CYTOMETRY STRATEGY BASED ON INTEGRATED DFN/LAIP APPROACH FOR MINIMAL/ MEASURABLE RESIDUAL DISEASE DIAGNOSIS AND MONITORING IN ACUTE MYELOID LEUKEMIA

EHA Library, Paula Piñero, 294396

MUTANT P53 INCREASES STEM-CELL FREQUENCY BUT IS ASSOCIATED WITH REDUCED BINDING TO CLASSICAL TP53 BINDING SITES IN PRIMARY AML AND CELL LINES

EHA Library, Mylene Gerritsen, 294397

MLL5-MEDIATED EPIGENETIC REPROGRAMMING PROMOTES HIGHER MYELOID DIFFERENTIATION IN RESPONSE TO RA-BASED TREATMENT IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Diego A Pereira-Martins, 294398

INHIBITION OF AKT DOWNSTREAM SIGNALLING ENHANCES CHEMOTHERAPY RESPONSE IN KIT MUTANT AML

EHA Library, Montserrat Estruch Alrich, 294399

LOSS OF MIR-155-5P INCREASED THE TREATMENT SENSITIVITY TO CHEMOTHERAPY AND FLT3 INHIBITORS IN FLT3-ITD+AML VIA GLYCOLYSIS BLOCKING BY TARGETING PIK3R1

EHA Library, Lingyan Wang, 294400

DNA METHYLATION PROFILING ENABLES PROGNOSTIC CLASSIFICATION OF INTENSIVELY TREATED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Sebastian Vosberg, 294401

MUTATIONAL PROFILE OF T(11;17)(Q23;Q21)/ZBTB16-RARA –POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Emiliano Fabiani, 294402

IDH2 P.R172K MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) MAY BE ASSOCIATED WITH FAVORABLE RESPONSE TO SELINEXOR TREATMENT

EHA Library, Christopher Walker, 294403

CHARACTERIZATION AND TRANSFER OF EXTRACELLULAR VESICLES WITHIN THE BONE MARROW NICHE IN ACUTE MYELOID LEUKEMIA

EHA Library, Judith S. Hecker, 294404

A MULTI-OMICS APPROACH TO UNRAVEL GPR56-MODULATED PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Lixiazi He, 294405

COMBINED TARGETING DNA DAMAGE RESPONSE AND ANTI-APOPTOTIC PROGRAMS IN AML

EHA Library, Viral Shah, 294406

POTENTIAL THERAPEUTIC IMPLICATION OF CIP2A-MEDIATED PP2A MODULATION IN MIXED LINEAGE LEUKEMIA

EHA Library, Antonella Di Mambro, 294407

ROLE OF CD276 IN REMODELLING OF THE BONE MARROW MICROENVIRONMENT DURING LEUKAEMIA PROGRESSION

EHA Library, Antoniana Batsivari, 294408

DYSREGULATED EXPRESSION OF MICRORNAS CONTRIBUTES TO INFLAMMATORY AND NEOPLASTIC CHARACTERISTICS OF ERDHEIM-CHESTER DISEASE

EHA Library, Ran Weissman, 294409

TP53 MUTATED AML IS ASSOCIATED WITH AN IMMUNE DYSFUNCTION

EHA Library, Ghayas C. Issa, 294410

NON-GENOTOXIC COMBINATION TREATMENTS FOR PAEDIATRIC ACUTE MYELOID LEUKAEMIA

EHA Library, Mojgan Reza, 294411

A NOVEL MECHANISM OF VENETOCLAX RESISTANCE IN ACUTE MYELOID LEUKEMIA: DELETION OF BAX

EHA Library, Farid Ahmed, 294412

DRUG REPOSITIONING OF CABOZANTINIB TO TREATMENT OF LEUKEMIC CELLS WITH RUNX1-RUNX1T1 AND KIT MUTATION

EHA Library, Kuan-Wei Su, 294413

ADDITION OF THE PARP INHIBITOR, TALAZOPARIB TO GEMTUZUMAB OZOGAMICIN SIGNIFICANTLY ENHANCES ANTI-LEUKEMIC ACTIVITY IN HUMAN CD33+ ACUTE MYELOID LEUKEMIA

EHA Library, Marianna Giorgi, 294414

BITTER TASTE RECEPTORS ARE EXPRESSED AND FUNCTIONAL IN BOTH HSC AND LEUKEMIC CELLS

EHA Library, Valentina Salvestrini, 294415

MEDS433; NEW GENERATION OF DIHYDROOROTATE DEHYDROGENASE (DHODH) INHIBITOR IN THE TREATMENT OF AML

EHA Library, Mohammad Houshmand, 294416

THERAPEUTIC POTENTIAL OF TENALISIB, A PI3K DELTA/GAMMA PLUS SIK-3 INHIBITOR, IN HEMATOLOGICAL MALIGNANCIES

EHA Library, Srikant Viswanadha, 294417

IDENTIFICATION OF POTENTIAL BIOMARKER FOR PREDICTING THE RESPONSE OF AML CELLS TO LYSINE SPECIFIC DEMETHYLASE 1 (LSD1) INHIBITORS

EHA Library, Amal Kamal Abdel-Aziz, 294418

COMPARATIVE TRANSCRIPTIONAL SIGNATURE OF PURIFIED ERYTHROBLASTS FROM ACUTE MYELOID LEUKEMIA AML 6A (FAB CLASSIFICATION) AND PURE ERYTHROID LEUKEMIA USING NANOSTRING TECHNOLOGY

EHA Library, A Caulier, 294419

PYRVINIUM PAMOATE PROMOTES CELL DEATH ASSOCIATED WITH INTEGRATED STRESS RESPONSE ON ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Yu-Hsuan Fu, 294420

EARLY DETERMINATION OF THE MEASURABLE RESIDUAL DISEASE AFTER ALLOGENEIC TRANSPLANT CARRIES PROGNOSTIC IMPLICATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Claudia Nunez-Torron Stock, 294421

ASTX295, A NOVEL SMALL MOLECULE MDM2 ANTAGONIST, DEMONSTRATES POTENT ACTIVITY IN AML IN COMBINATION WITH DECITABINE

EHA Library, Luke Bevan, 294423

BISPECIFIC T-CELL ENGAGER ANTIBODIES MAY CONTRIBUTE TO REACTIVATE PRE-EXISTING TUMOR SPECIFIC T-CELLS

EHA Library, Joan Ballesteros, 294424

MINIMAL RESIDUAL DISEASE AND COMPLETE MOLECULAR EVALUATION IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA: A SINGLE CENTER STUDY

EHA Library, Mara Memoli, 294425

THE ONCOPROTEIN SKI IS ASSOCIATED WITH A SHORTER OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE AND A MUTATED RECEPTOR TYROSINE KINASE FLT3ITD

EHA Library, Miriam Frech, 294426

SINGLE CELL PROFILING OF BCL-2 FAMILY MEMBERS AND CLEAVED CASPASE-3 IN SEARCH OF BIOMARKERS FOR VENETOCLAX TREATMENT IN ACUTE MYELOID LEUKEMIA

EHA Library, Oda Helen Eck Fagerholt, 294427

PREFERENTIAL TRANSCRIPTION AND TARGETING OF THE MUTATED ALLELE IN NPM1 MUTATED ACUTE MYELOID LEUKAEMIA

EHA Library, Graham Bailey, 294428

ANALYTICAL PERFORMANCES OF RNA SEQUENCING FOR THE DIAGNOSIS OF HAEMATOLOGICAL MALIGNANCIES

EHA Library, Sarah Huet, 294429

LEF1-AS1, LONG NON-CODING RNA, IS A NEW PLAYER IN HUMAN ERYTHROID DIFFERENTIATION

EHA Library, Ada Congrains Castillo, 294430

RADICICOL AS A MODULATOR TO REVERT WARBURG EFFECT ON CABOZANTINIB-RESISTANT MYELOID LEUKEMIA CELLS WITH FLT3-ITD

EHA Library, Yu-Hsuan Fu, 294431

INVESTIGATION OF NUCLEOPHOSMIN1 AND IDH MUTATIONS BY DIGITAL DROPLET PCR IN ACUTE MYELOID LEUKEMIA

EHA Library, Petra Kovy, 294432

HIGH MUTANT ALLELE BURDEN OF ASXL1 GENE IS A POOR PROGNOSIS FACTOR FOR ADULT ACUTE MYELOID LEUKEMIA

EHA Library, Yanfang Liu, 294433

COMPUTATIONAL APPROACHES FOR RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA

EHA Library, Costa Bachas, 294434

HARNESSING GENE EXPRESSION PROFILES FOR THE IDENTIFICATION OF DRUG RESISTANCE GENES IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, David GJ Cucchi, 294435

BIOLOGY OF T(6;11) FUSION GENES AND THEIR ROLE IN MLL-REARRANGED ACUTE LEUKEMIA LINEAGE DETERMINATION

EHA Library, Arpita Kundu, 294436

QUANTITATIVE EVALUATION AND MONITORING OF RESIDUAL DISEASE USING WILMS' TUMOR 1 (WT1) GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA TREATED WITH DECITABINE

EHA Library, Anna Candoni, 294437

EXPOSURE-MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) RESPONSE ANALYSIS OF THE MDM2 ANTAGONIST KRT-232 IN PATIENTS WITH ADVANCED SOLID TUMORS, MULTIPLE MYELOMA, OR ACUTE MYELOID LEUKEMIA

EHA Library, Martine Allard, 294438

GALECTIN-9 OVERCOMES THERAPY RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Valerie Wiersma, 294439

ADVANTAGES AND LIMITATIONS OF CULTURED MESENCHYMAL STROMAL CELLS (MSC) FROM ACUTE MYELOID LEUKEMIA (AML) PATIENTS AS A SOURCE OF GERMLINE DNA FOR SEQUENCING STUDIES

EHA Library, F Guijarro, 294440

EVOLUTION OF STEM CELL FREQUENCY AND CORRELATION WITH THE IMMUNOPHENOTYPE DURING SERIAL TRANSPLANTATION IN A CALM/AF10 LEUKEMIA MODEL

EHA Library, Niloofar Zandvakili, 294442

CHAPERONE-MEDIATED AUTOPHAGY IN NORMAL AND ACUTE MYELOID LEUKEMIA GRANULOCYTIC DIFFERENTIATION

EHA Library, Sreoshee Rafiq, 294443

GENETIC CHARACTERIZATION OF ACUTE MYELOID LEUKAEMIA PATIENTS WITH MUTATIONS IN IDH1/2 GENES

EHA Library, Pamela Acha, 294444

EFFECT OF HISTONE DEACETYLASE INHIBITOR CHIDAMIDE IN ACUTE PROMYELOCYTIC LEUKEMIA VARIANTS

EHA Library, Nannan Liu, 294445

THE M6A RNA METHYLTRANSFERASE METTL3/METTL14 PROMOTES LEUKEMOGENESIS THROUGH THE MDM2/P53 PATHWAY IN ACUTE MYELOID LEUKEMIA

EHA Library, Lina Sang, 294446

GENETIC AND PHENOTYPIC CHARACTERIZATION OF SUBCLONES IN ACUTE MYELOID LEUKEMIA

EHA Library, Francesca Tiso, 294447

MUTATIONAL SPECTRUM AND PROGNOSIS IN NRAS-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Shujuan Wang, 294448

SORAFENIB AS MAINTENANCE FOR PREVENTING RELAPSE IN FLT3-ITD ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN RANDOMIZED, MULTICENTER, PHASE 3 TRIAL

EHA Library, Li Xuan, 294449

A RANDOMIZED DOUBLE-BLIND PHASE 3 TRIAL OF CYTARABINE WITH MDM2 INHIBITOR IDASANUTLIN OR PLACEBO IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML): PRIMARY ANALYSIS RESULTS OF THE MIRROS STUDY

EHA Library, Marina Y. Konopleva, 294450

TAGRAXOFUSP (SL-401), A CD123-DIRECTED THERAPY, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): GENOMIC LANDSCAPE AND LONG-TERM RESULTS OF A LANDMARK CLINICAL TRIAL

EHA Library, Naveen Pemmaraju, 294451

CLINICAL OUTCOMES OF OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) RECEIVING HYPOMETHYLATING AGENTS: A LARGE POPULATION-BASED STUDY IN THE UNITED STATES

EHA Library, Rory Shallis, 294452

TIMING OF RESPONSE TO VENETOCLAX COMBINATION TREATMENT IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Brian Jonas, 294453

REMISSION AND SURVIVAL AFTER 90 MG VERSUS 60 MG DAUNORUBICIN IN 7+3 STANDARD INDUCTION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS FROM THE RANDOMIZED CONTROLLED SAL-DAUNODOUBLE TRIAL

EHA Library, Christoph Röllig, 294454

HIGHER PERCENTAGE OF LEUKEMIC STEM CELLS (LSC) AT DIAGNOSIS AND LSC MEASURABLE RESIDUAL STATUS (MRD) POSITIVITY PREDICTS INFERIOR OUTCOME IN ADULT ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Chinmayee Nandkumar Kakirde, 294455

UPDATE FROM THE ONGOING PHASE I MULTINATIONAL STUDY OF MCLA-117, A BISPECIFIC CLEC12A X CD3 T-CELL ENGAGER, IN PATIENTS (PTS) WITH ACUTE MYELOGENOUS LEUKEMIA (AML)

EHA Library, John Mascarenhas, 294456

VALIDATION OF A GENE EXPRESSION BASED CLASSIFIER FOR THE PREDICTION OF RESISTANCE TO INDUCTION TREATMENT IN ACUTE MYELOID LEUKEMIA

EHA Library, Christian Moser, 294457

IVOSIDENIB IMPROVES OVERALL SURVIVAL RELATIVE TO STANDARD THERAPIES IN RELAPSED OR REFRACTORY MUTANT IDH1 AML: RESULTS FROM MATCHED COMPARISONS TO HISTORICAL CONTROLS

EHA Library, Peter Paschka, 294458

YOUNGER PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTANT AML TREATED WITH CRENOLANIB PLUS CHEMOTHERAPY ACHIEVE DURABLE REMISSIONS

EHA Library, Boo Messahel, 294459

SEQUENTIAL FLT3 AND NGS BASED MUTATIONAL ANALYSIS IN RELAPSED FLT-3 POSITIVE AML POST FLT3- INHIBITORS BASED THERAPY.

EHA Library, Ahmad S Alotaibi, 294460

LONG-TERM SURVIVORS AND SAFETY BEYOND 1 YEAR OF GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: FOLLOW-UP OF THE ADMIRAL PHASE 3 TRIAL

EHA Library, Alexander Perl, 294461

LOMUSTINE IS BENEFICIAL TO OLDER AML PATIENTS WITH AN ELN2017 ADVERSE RISK PROFILE AND AN INTERMEDIATE KARYOTYPE: RESULTS OF THE LAMSA-2007. A FILO TRIAL.

EHA Library, Eric DELABESSE, 294462

GLASDEGIB (GLAS) PLUS LOW-DOSE CYTARABINE (LDAC) IN AML OR MDS: BRIGHT AML 1003 FINAL REPORT AND 4-YEAR OVERALL SURVIVAL (OS) FOLLOW-UP.

EHA Library, Michael Heuser, 294463

OUTCOMES AND TREATMENT PATTERNS OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITHOUT TARGETED AGENTS: REAL-WORLD BENCHMARKS FOR FUTURE STUDIES FROM THE GERMAN SAL REGISTRY

EHA Library, Christoph Röllig, 294464

PROGNOSTIC AND THERAPEUTIC IMPLICATIONS OF MUTANT TP53 VARIANT ALLELIC FREQUENCY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Nicholas Short, 294465

UPDATED RESULTS FROM A PHASE 1 FIRST-IN-HUMAN DOSE ESCALATION STUDY OF AMG 673, A NOVEL ANTI-CD33/CD3 BITE® (BISPECIFIC T-CELL ENGAGER) IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Marion Subklewe, 294466

CHARACTERISTICS AND CLINICAL OUTCOMES OF MLL REARRANGEMENTS IN ADULTS WITH AML

EHA Library, Jabra Zarka, 294467

CC-486 MAINTENANCE THERAPY IS SAFE AND WELL TOLERATED IN PATIENTS AGED ≥75 YEARS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST REMISSION FOLLOWING INDUCTION CHEMOTHERAPY: RESULTS FROM QUAZAR AML-001

EHA Library, Farhad Ravandi, 294468

ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML

EHA Library, Joshua Zeidner, 294469

IS ASSESSMENT OF BONE MARROW DYSPLASIA STILL RELEVANT IN ACUTE MYELOID LEUKEMIAS IN THE GENOMICS ERA? A REPORT FROM THE ACUTE LEUKEMIA FRENCH ASSOCIATION

EHA Library, Matthieu Duchmann, 294470